Extended Data Fig. 2: Evidence that benefits from vaccination outweigh risks.
From: A framework for risk–benefit analysis of vaccines approved through accelerated pathways
Probability that vaccine benefits outweigh the risks of vaccine SAEs assuming different probabilities of severe outcomes following infection, probabilities of SAEs and either 1,000 or 10,000 individuals vaccinated (cohort size). Estimates are shown for different epidemiological scenarios (columns), assuming 50% or 95% vaccine efficacy (rows). n = 100,000 posterior samples. SAE: serious adverse event.
